Projecten per jaar
Vingerafdruk
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Projecten
- 1 Actief
-
ANI323: Gepersonaliseerde tumor-afgeleide dendritische celtherapie om restziekte bij multipel myeloom te overwinnen
1/11/22 → 31/10/23
Project: Fundamenteel
-
Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism
Satilmis, H., Verheye, E., Vlummens, P., Oudaert, I., Vandewalle, N., Fan, R., Knight, J., De Beule, N., Ates, G., Massie, A., Moreaux, J., Maes, A., De Bruyne, E., Vanderkerken, K., Menu, E., Sloan, E. & De Veirman, K., jan 2023, In: Journal of pathology. 259, 1, blz. 69–80 12 blz.Onderzoeksoutput: Article › peer review
Open Access2 Citaten (Scopus) -
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
Fan, R., Satilmis, H., Vandewalle, N., Verheye, E., Vlummens, P., Maes, A., Muylaert, C., De Bruyne, E., Menu, E., Evans, H., Chantry, A., De Beule, N., Hose, D., Töngren, M., Eriksson, H., Vanderkerken, K., Maes, K., Breckpot, K. & De Veirman, K., 17 jan 2023, In: Journal for ImmunoTherapy Of Cancer. 11, 1, A8.Onderzoeksoutput: Article › peer review
Open Access1 Citaat (Scopus) -
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
Verheye, E., Melgar, J. B., Deschoemaeker, S., Raes, G., Maes, A., De Bruyne, E., Menu, E., Vanderkerken, K., Laoui, D. & De Veirman, K., 14 jan 2022, In: International Journal of Molecular Sciences. 23, 2, 904.Onderzoeksoutput: Scientific review › peer review
Open Access17 Citaten (Scopus) -
Dendritische cellen als immunotherapie voor multipel myeloom
Verheye, E., De Beule, N., Laoui, D. & De Veirman, K., 2022, In: OncoHemato. 16, 3, blz. 35-38 4 blz.Onderzoeksoutput: Article › peer review
-
The multifaceted anti-cancer effects of the immunomodulator Tasquinimod in Multiple Myeloma
Fan, R., Verheye, E., Satilmis, H., Vandewalle, N., De Bruyne, E., Menu, E., De Beule, N., Hose, D., Vanderkerken, K., Breckpot, K., Maes, K. & De Veirman, K., 4 feb 2022.Onderzoeksoutput: Poster
Activiteiten
- 2 Talk or presentation at a conference
-
Mapping the immune heterogeneity within the myeloma microenvironment using single-cell transcriptomics
Emma Verheye (Speaker), Rong Fan (Contributor), Hatice Satilmis (Contributor), Niels Vandewalle (Contributor), Pauline Bardet (Contributor), Emile Clappaert (Contributor), Daliya Kancheva (Contributor), Elke De Bruyne (Contributor), Karin Vanderkerken (Contributor), Kim De Veirman (Contributor) & Damya Laoui (Contributor)
3 feb 2023Activiteit: Talk or presentation at a conference
-
AXL targeting using Bemcentinib increases chemosensitivity in Acute Myeloid Leukemia
Niels Vandewalle (Speaker), Laura Meysman (Contributor), Nathan De Beule (Contributor), Ann De Becker (Contributor), Hatice Satilmis (Contributor), Emma Verheye (Contributor), Rong Fan (Contributor), Elke De Bruyne (Contributor), Eline Menu (Contributor), Karin Vanderkerken (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Kim De Veirman (Contributor)
3 feb 2023Activiteit: Talk or presentation at a conference
Scriptie
-
Daily management of an animal facility in preparation of AAALAC acreditation
Auteur: Verheye, E., 2020Begeleider: Hellemans, K. (Promotor)
Scriptie/Masterproef: Master's Thesis
-
Stress hormone signalling contributes to myelomagenesis by effects on immune cells and tumor cells
Auteur: De Veirman, K. & Verheye, E. M., 2021Scriptie/Masterproef: Master's Thesis